These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3499514)

  • 1. Diminution of the T8 subset by amiprilose hydrochloride in refractory RA.
    Weinblatt ME; Fraser PA; Anderson R; Coblyn JS; Trentham DE
    J Rheumatol; 1987 Aug; 14(4):859-60. PubMed ID: 3499514
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiprilose hydrochloride for rheumatoid arthritis.
    Riskin WG; Gillings DB; Scarlett JA
    Ann Intern Med; 1989 Sep; 111(6):455-65. PubMed ID: 2672925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a modified hexose sugar, amiprilose hydrochloride, in experimental models of synovitis.
    Kieval RI; Young CT; Prohazka D; Brinckerhoff CE; Trentham DE
    J Rheumatol; 1989 Jan; 16(1):67-74. PubMed ID: 2785600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study.
    Caldwell JR; Furst DE; Smith AL; Clark JA; Bonebrake RA; Gruhn WB; McIlwain HH; Logue CM
    J Rheumatol; 1998 Jan; 25(1):30-5. PubMed ID: 9458199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The active rosette-formation reaction in assessing the immunomodulating activity of basic preparations in patients with rheumatoid arthritis].
    Senchilo IV; Vasil'eva EV
    Ter Arkh; 1992; 64(6):77-80. PubMed ID: 1440346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the use of salazopyrine EN in patients with spondylarthritis ankylopoietica and rheumatoid arthritis].
    Somhegyi A; Gömör B
    Orv Hetil; 1988 Sep; 129(36):1917-21. PubMed ID: 2902550
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunomodulating basic therapy of rheumatoid arthritis using ciamexone].
    Baerwald C; Goebel KM; Krause A; Heymanns J
    Schweiz Med Wochenschr; 1989 Dec; 119(49):1769-71. PubMed ID: 2533393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined immunomodulating therapy in rheumatoid arthritis].
    Oliunin IuA; Balabanova RM
    Ter Arkh; 1996; 68(5):13-6. PubMed ID: 9082588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of rheumatoid polyarthritis with salazosulfapyridine].
    Nolla JM; Fiter J; Mateo L
    Rev Rhum Mal Osteoartic; 1992 Jan; 59(1):84. PubMed ID: 1349766
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characterization of imuthiol.
    Lemarie E; Musset M; Charbonnier C; Renoux M; Renoux G
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):51-4. PubMed ID: 3010015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulators in the therapy of rheumatoid arthritis. I. The use of thymalin].
    Melekhin VD; Siniachenko VV; Khavinson VKh; Morozov VG
    Revmatologiia (Mosk); 1985; (3):43-6. PubMed ID: 3903930
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheumatoid arthritis and the intestinal microbiocenosis].
    Frizen BN
    Ter Arkh; 1994; 66(5):17-21. PubMed ID: 7940329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subreum efficacy and tolerance in patients with early rheumatic arthritis].
    Stepanets OV; Chichasova NV; Nasonova MB; Nasonov EL
    Klin Med (Mosk); 2001; 79(11):58-62. PubMed ID: 11811114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial results of the clinical use of the immunostimulant bestatin (3-amino-2-hydroxy-4-phenylbutyryl leucine) in patients with chronic polyarthritis].
    Meske S; Vogt P; Maly FE; Seitz M; Müller W
    Z Rheumatol; 1985; 44(5):231-6. PubMed ID: 4082790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
    Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
    Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide-induced toxic epidermal necrolysis.
    Teraki Y; Hitomi K; Sato Y; Hamamatsu Y; Izaki S
    Int J Dermatol; 2006 Nov; 45(11):1370-1. PubMed ID: 17076730
    [No Abstract]   [Full Text] [Related]  

  • 17. Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis.
    Lacki JK; Müller-Ruchholtz W; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):285-8. PubMed ID: 9523002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Salazopyrine in the treatment of rheumatoid arthritis].
    Villar Grimalt A; Puche Azorín P
    Med Clin (Barc); 1987 Mar; 88(12):519-20. PubMed ID: 2884366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor necrosis factor modulators in the treatment of rheumatoid arthritis].
    Konttinen YT; Valleala H; Honkanen V; Törnwall J; Tensing EK; Sorsa T; Nordström D
    Duodecim; 1999; 115(18):1969-76. PubMed ID: 11941814
    [No Abstract]   [Full Text] [Related]  

  • 20. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
    Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.